Robert Gross, MD

Professional Titles

• Assistant Professor

Publications

• Gross RH, Corboy J. De-escalation and Discontinuation of Disease-Modifying Therapies in Multiple Sclerosis. Curr Neurol Neurosci Rep. 2024 Sep;24(9):341-353. PubMed PMID: 38995483
• Barrera, B., Simpson, H., Engebretson, E., Sillau, S., Valdez, B., Parra-González, J., Winger, R.C., Epperson, L.A., Banks, A., Pierce, K., Spotts, M., O'Gean, K., Alvarez, E., Gross, R., Piquet, A.L., Schreiner, T., Corboy, J.R., Pei, J., Vollmer, T.L. and Nair, K.V. Safety and patient experience with at-home infusion of ocrelizumab for multiple sclerosis. Ann Clin Transl Neurol 2023 Apr; 10(4):579-588. https://doi.org/10.1002/acn3.51745
• Spain RI, Hildebrand A, Waslo CS, Rooney WD, Emmons J, Schwartz DL, Freedman MS, Mateo Paz Soldan M, Repovic P, Solomon AJ, Rinker J, Wallin M, Haselkorn J, Stuve O, Gross RH, Turner AP. Processing speed and memory test performance are associated with different brain region volumes in Veterans and others with progressive multiple sclerosis. Front Neurol 2023 Jun; 14:1188124 https://doi.org/10.3389/fneur.2023.1188124
• Borko TL, Baxter R, Cabrera-Martinez B, Thiruppathi E, Sabalza M, Venkataraman I, Selva S, Rester C, Sillau S, Pastula DM, Bennett JL, Alvarez E, Gross R, Shah A, Kammeyer R, Corboy JR, Kedl RM, Hsieh EWY, Piquet AL. SARS-CoV-2 mRNA Vaccination Induces an Antigen-Specific T Cell Response Correlating with Plasma Interferon-gamma in B Cell Depleted Patients. J Neuroimmunol 2023 Oct. 383:578192. doi: 10.1016/j.jneuroim.2023.578192
• Gross R, Selva S, Ritchie A, Sillau S. Using Plasma NfL and GFAP to Monitor Response to Anti-CD20 Treatment in MS. Poster presentation at American Academy of Neurology Annual Meeting; Apr 22- 27, 2023; Boston, MA.
• Borko TL, Barrera B, Ritchie A, Selva S, Sillau S, Engebretson E, Seale R, Valdez B, Alvarez E, Corboy J, Shah A, Gross R, Silva D, Owens G, Piquet AL, Bennett JL, Vollmer TL, Chahin S, Nair KV. Establishing Demographic and Comorbidity based Reference Ranges for NfL and GFAP in Healthy Controls. Poster presentation at American Academy of Neurology Annual Meeting; Apr 22- 27, 2023; Boston, MA.
• Borko TL, Barrera B, Ritchie A, Selva S, Sillau S, Engebretson E, Seale R, Valdez B, Alvarez E, Corboy J, Shah A, Gross R, Silva D, Owens G, Piquet AL, Bennett JL, Vollmer TL, Chahin S, Nair KV. Establishing Baseline Demographic Specific Reference Ranges for NfL and GFAP in Healthy Controls. Poster presentation at ACTRIMS Forum February 23-25, 2023; San Diego, CA.
• Piquet AL, Alvarez E (Eds.) “Use of Disease-Modifying Therapies in Multiple Sclerosis.” John Corboy and Robert Gross. Neuroimmunology: Multiple Sclerosis, Autoimmune Neurology, and Related Diseases. Springer: 2021, pp 493-506.
• Gross RH, Corboy JR. Monitoring, Switching, and Stopping Multiple Sclerosis Disease-Modifying Therapies. Continuum (Minneap Minn). 2019 Jun;25(3):715-735. PubMed PMID: 31162313

Practice Locations

UCHealth Neurosciences Center - Anschutz Medical Campus
1635 Aurora Ct
4th Floor
Aurora, CO 80045
720-848-2080

UCHealth Anschutz Outpatient Pavilion - Anschutz Medical Campus
1635 Aurora Ct
Aurora, CO 80045
720-848-0000

Rocky Mountain Regional Veterans Administration Medical Center
1700 Wheeling St
Aurora, CO 80045
303-399-8020

Hospital Affiliation

• University of Colorado Hospital
• Veterans Affairs Medical Center

Center Affiliations

• Rocky Mountain Multiple Sclerosis Center

Specialty Information

Specialties

• Neurology, Board Certification
• Neuroimmunology

Conditions & Treatments

• Brain and Nervous System
• Brain and Nervous System - Multiple Sclerosis